{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:16:40Z","timestamp":1741839400519,"version":"3.38.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1918,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1002\/hep.23601","type":"journal-article","created":{"date-parts":[[2010,2,19]],"date-time":"2010-02-19T20:24:19Z","timestamp":1266611059000},"page":"1891-1893","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Effects of Sustained Virologic Response on the Development of Esophageal Varices in Compensated Cirrhosis: \u201cIs the Bang Worth the Buck?\u201d"],"prefix":"10.1097","volume":"51","author":[{"given":"Richard K.","family":"Sterling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20250312","doi-asserted-by":"crossref","first-page":"463472","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type C: a retrospective followup study of 384 patients.","volume":"112","author":"Fattovich","year":"1997","journal-title":"Gastroenterology"},{"key":"R2-4-20250312","doi-asserted-by":"crossref","first-page":"11471158","DOI":"10.1038\/ajg.2009.31","article-title":"Predicting mortality risk in patients with compensated HCVinduced cirrhosis: a longterm prospective study.","volume":"104","author":"Bruno","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R3-4-20250312","doi-asserted-by":"crossref","first-page":"318327","DOI":"10.1016\/j.dld.2007.12.004","article-title":"Portal hypertension: preprimary and primary prophylaxis of variceal bleeding.","volume":"40","author":"Tiani","year":"2008","journal-title":"Dig Liver Dis"},{"key":"R4-4-20250312","first-page":"178186","article-title":"Review: the modern management of portal hypertensionprimary and secondary prophylaxis of variceal bleeding in cirrhotic patients.","volume":"28","author":"GarciaPagan","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R5-4-20250312","doi-asserted-by":"crossref","first-page":"22542261","DOI":"10.1056\/NEJMoa044456","article-title":"; Portal Hypertension Collaborative Group. Betablockers to prevent gastroesophageal varices in patients with cirrhosis.","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-4-20250312","doi-asserted-by":"crossref","first-page":"388397","DOI":"10.1002\/hep.23340","article-title":"Efficacy and safety of peginterferon alfa2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis.","volume":"51","author":"Bruno","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R7-4-20250312","doi-asserted-by":"crossref","first-page":"677684","DOI":"10.7326\/0003-4819-147-10-200711200-00003","article-title":"Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.","volume":"147","author":"Veldt","year":"2007","journal-title":"Ann Intern Med"},{"key":"R8-4-20250312","doi-asserted-by":"crossref","first-page":"196197","DOI":"10.1016\/S0140-6736(00)03595-9","article-title":"Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis.","volume":"357","author":"Nishiguchi","year":"2001","journal-title":"Lancet"},{"key":"R9-4-20250312","doi-asserted-by":"crossref","first-page":"579587","DOI":"10.1002\/hep.21492","article-title":"; Italian Association of the Study of the Liver Disease (AISF). Sustained virological response to interferonalpha is associated with improved outcome in HCVrelated cirrhosis: a retrospective study.","volume":"45","author":"Bruno","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R10-4-20250312","doi-asserted-by":"crossref","first-page":"13031313","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.","volume":"122","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"R11-4-20250312","doi-asserted-by":"crossref","first-page":"542551","DOI":"10.1111\/j.1365-2036.2008.03620.x","article-title":"Histological benefits of virological response to peginterferon alfa2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis.","volume":"27","author":"Everson","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-4-20250312","doi-asserted-by":"crossref","first-page":"729738","DOI":"10.1002\/hep.22694","article-title":"Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5year followup of 150 patients.","volume":"49","author":"George","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R13-4-20250312","doi-asserted-by":"crossref","first-page":"22692274","DOI":"10.1111\/j.1572-0241.2006.00743.x","article-title":"Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis.","volume":"101","author":"Rincon","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R14-4-20250312","doi-asserted-by":"crossref","first-page":"932937","DOI":"10.1016\/j.cgh.2007.02.022","article-title":"Effect of sustained viral response on hepatic venous pressure gradient in hepatitis Crelated cirrhosis.","volume":"5","author":"Roberts","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R15-4-20250312","doi-asserted-by":"crossref","first-page":"24292441","DOI":"10.1056\/NEJMoa0707615","article-title":"; HALTC Trial Investigators. Prolonged therapy of advanced chronic hepatitis C with lowdose peginterferon.","volume":"359","author":"Di Bisceglie","year":"2008","journal-title":"N Engl J Med"},{"key":"R16-4-20250312","doi-asserted-by":"crossref","first-page":"19861994","DOI":"10.1053\/j.gastro.2009.08.067","article-title":"; HALTC Trial Group. Effect of HCV RNA suppression during peginterferon alfa2a maintenance therapy on clinical outcomes in the HALTC trial.","volume":"137","author":"Shiffman","year":"2009","journal-title":"Gastroenterology"},{"key":"R17-4-20250312","doi-asserted-by":"crossref","first-page":"20692076","DOI":"10.1002\/hep.23528","article-title":"Redailli A; Sustained virologic response prevents the development of esophageal varices in compensated, childpugh class a hepatitis C virusinduced cirrhosis. A 12year prospective followup study.","volume":"51","author":"Bruno","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R18-4-20250312","first-page":"12081236","article-title":"Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma.","volume":"42","author":"Bruix","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R19-4-20250312","doi-asserted-by":"crossref","first-page":"255262","DOI":"10.1002\/hep.20793","article-title":"Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy.","volume":"42","author":"Everson","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R20-4-20250312","doi-asserted-by":"crossref","first-page":"64676472","DOI":"10.3748\/wjg.14.6467","article-title":"Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition.","volume":"14","author":"Iacobellis","year":"2008","journal-title":"World J Gastroenterol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23601","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201006000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:08:30Z","timestamp":1741777710000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201006000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23601","relation":{},"ISSN":["0270-9139"],"issn-type":[{"type":"print","value":"0270-9139"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}